pmid,doi,title,journal,year,abstract_length,methods_length,intro_length,existing_tool_count,novel_tool_count,total_tool_count,existing_tools,novel_tools,tool_metadata,tool_sources,is_gff
10215625,10.1101/gad.13.8.978,Schwann cell hyperplasia and tumors in transgenic mice expressing a naturally occurring mutant NF2 protein.,Genes Dev,1999,790,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Specific mutations in some tumor suppressor genes such as p53 can act in a dominant fashion. We tested whether this mechanism may also apply for the neurofibromatosis type-2 gene (NF"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
10383727,10.1046/j.1523-1747.1999.00609.x,"The Nf1 tumor suppressor regulates mouse skin wound healing, fibroblast proliferation, and collagen deposited by fibroblasts.",J Invest Dermatol,1999,1339,0,0,2,1,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {""Nf1+/-"": ""d27fd7b0-ed8f-4ee2-a8d9-26748c12518c""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""gen matrix produced by fibroblasts. Trauma has been proposed to trigger neurofibroma formation. To test if loss of the neurofibromatosis type 1 gene (Nf1) compromises fibroblast function in vivo following trauma, skin wounding was performed in Nf1 knockout mice. The pattern and amount of collagen-rich "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""animal_models:Nf1+/-"": {""context"": ""med in Nf1 knockout mice. The pattern and amount of collagen-rich granulation bed tissue, manufactured by fibroblasts, was grossly abnormal in 60% of Nf1+/- wounds. Nf1 mutant fibroblasts showed cell autonomous abnormalities in collagen deposition in vitro that were not mimicked by Ras activation in fibro"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 patients develop peripheral nerve tumors (neurofibromas) composed mainly of Schwann cells and fibroblasts, in an abundant collage"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""animal_models:Nf1+/-"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
10433955,10.1016/S0002-9440(10)65158-9,Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas.,Am J Pathol,1999,1511,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Ependymal tumors are heterogeneous with regard to morphology, localization, age at first clinical manifestation, and prognosis. Several molecular alterations have be"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
10567424,10.1074/jbc.274.48.34438,Interdomain interaction of merlin isoforms and its influence on intermolecular binding to NHE-RF.,J Biol Chem,1999,1428,15631,0,1,2,3,"{""cell_lines"": {""HEK293"": ""7b6dcc42-3c32-4008-8b2c-309aa01b17be""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials and Methods Plasmids,\nCloning, and Mutagenesis Synthetic genes\nencoding for human merlin FERM (P35240; amino acids 22\u2013312)\nand radixin FERM (P352"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:HEK293"": {""context"": "" coefficient\nwas found to be around 1 for all experiments. All measurements were\nperformed at least in triplicates. Cell Culture and Pull-Down\nAssays HEK293 cells (Sigma:85120602)\nwere cultured using Dulbecco\u2019s modified Eagle medium (Gibco)\nsupplemented with 10% fetal bovine serum and NEAA (Gibco) in a hu"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""abeled peptide was added to each\nsample. After mixing, the FP signals were recorded using SpectraMax\niD5 (Molecular Devices). Data were analyzed with GraphPad Prism version\n7.0.0 for MacOS (GraphPad Software, San Diego, California USA). A\nquadratic equation for equilibrium binding  was used to fit the obtained da"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""abstract"", ""methods""], ""cell_lines:HEK293"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""]}",False
10591653,10.1126/science.286.5447.2176,Mouse tumor model for neurofibromatosis type 1.,Science,1999,636,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder characterized by increased incidence of benign and malignant tumors of neural crest origin. Mutations that activat"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder characterized by increased incidence of benign and malignant tumors of neural crest origi"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
10595915,10.1016/S0002-9440(10)65504-6,Deletions of the INK4A gene occur in malignant peripheral nerve sheath tumors but not in neurofibromas.,Am J Pathol,1999,1546,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The INK4A gene, a candidate tumor suppressor gene located on chromosome 9p21, encodes two protein products, p16 and p19(ARF). p16 is a negative cell cycle regulator capable of arresti"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
10595919,10.1016/S0002-9440(10)65508-3,Expression of p27(kip) and other cell cycle regulators in malignant peripheral nerve sheath tumors and neurofibromas: the emerging role of p27(kip) in malignant transformation of neurofibromas.,Am J Pathol,1999,1393,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""There is little information regarding the status of cell cycle regulators in malignant peripheral nerve sheath tumors (MPNSTs) and neurofibromas (NFs). In"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
10620616,10.1084/jem.191.1.181,Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo.,J Exp Med,2000,1916,5444,0,2,1,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {""Nf1-/-"": ""b705a9f5-84ef-404e-9fe4-d499550298b3""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Materials and Methods Animals. \n Nf1 +/\u2212 mice were obtained from Dr. Tyler Jacks at the Massachusetts Institute of Technology (Cambridge, MA) in a C57BL/6.129 background, and were backcr"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""animal_models:Nf1-/-"": {""context"": ""ozygous inactivation of Nf1 are largely unknown. Recently neurofibromin, the protein encoded by NF1, was shown to negatively regulate Ras activity in Nf1-/- murine myeloid hematopoietic cells in vitro through the c-kit receptor tyrosine kinase (dominant white spotting, W). Since the W and Nf1 locus appear"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Materials and Methods Animals. \n Nf1 +/\u2212 mice were obtained from Dr. Tyler Jacks at the Massachusetts Institute of Technology (Cambridge, MA) in a C57BL/6."", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""abstract"", ""methods""], ""animal_models:Nf1-/-"": [""abstract""], ""computational_tools:R"": [""abstract"", ""methods""]}",False
10627474,,Inhibition of juvenile myelomonocytic leukemia cell growth in vitro by farnesyltransferase inhibitors.,Blood,2000,1851,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Juvenile myelomonocytic leukemia (JMML) is an early childhood disease for which there is no effective therapy. Therapy with 13-cis retinoic acid or low-dose chemotherapy can induce some responses, bu"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
10633134,10.1136/jmg.37.1.44,A search for evidence of somatic mutations in the NF1 gene.,J Med Genet,2000,1368,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type I (NF1) is an autosomal dominant disorder affecting 1 in 3000 people. The NF1 gene is located on chromosome 17q11.2, spans 350 kb of genomic DNA, and contai"", ""confidence"": 0.75, ""is_development"": true, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type I (NF1) is an autosomal dominant disorder affecting 1 in 3000 people. The NF1 gene is located on chromosome 17q11.2, spans 350 kb o"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
10669747,10.1128/MCB.20.5.1699-1712.2000,"Cloning and characterization of SCHIP-1, a novel protein interacting specifically with spliced isoforms and naturally occurring mutant NF2 proteins.",Mol Cell Biol,2000,1372,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The neurofibromatosis type 2 (NF2) protein, known as schwannomin or merlin, is a tumor suppressor involved in NF2-associated and sporadic schwannomas and meni"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
10678181,10.1016/s1097-2765(00)80415-3,Nf1 and Gmcsf interact in myeloid leukemogenesis.,Mol Cell,2000,862,6356,0,2,4,6,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {""Nf1-/-"": ""b705a9f5-84ef-404e-9fe4-d499550298b3""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""ImageJ"", ""R"", ""GraphPad Prism"", ""FlowJo""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""(Proteome Profiler Mouse XL Cytokine Array, R&D Systems, Minneapolis, MN, USA). In brief, protein lysates were prepared from the paraspinal tumors of Nf1 f/f ; DhhCre mouse neurofibromas, which exhibited a global deletion of either GM-CSFR-\u03b1 or GM-CSFR-\u03b2c. The arrays were conducted according to the ins"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""animal_models:Nf1-/-"": {""context"": ""ose cultures. We generated hematopoietic cells deficient in both Nf1 and Gmcsf to test whether GM-CSF is required to drive excessive proliferation of Nf1-/- cells in vivo. Here we show that GM-CSF play a central role in establishing and maintaining the MPD and that recipients engrafted with Nf1-/- Gmcsf-/"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""2. Materials and Methods 2.1. Mice GM-CSFR-\u03b1 and the GM-CSFR \u03b2 c  knockout mice on a C57BL/6 background were a kind gift from Bruce C. Trapnell (CCHMC). Mouse"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""d and dorsal root ganglia (DRG) in 7-month-old mice. Image snapshots of dissected spinal cords with the attached nerves were taken and analyzed using ImageJ. (V.1.53k). A DRG with a diameter >1 mm, measured parallel to the spinal axis, was defined as a tumor. 2.3. Immunofluorescence (IF) and Immunohistoch"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""multiple comparisons as appropriate. A  p -value < 0.05 is considered significant. Generation of graphs and statistical analyses were performed using GraphPad Prism v.10."", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:FlowJo"": {""context"": ""2, Biolegend), and several others. Samples were analyzed with the Aurora cell multiparametric flow analyzer (Cytek Biosciences, Fremont, CA, USA) and FlowJO_V10 or SpectroFlo 3.3.0 software. 2.5. Mouse Cytokine Array Analysis Mouse cytokine protein expressions were quantified using a mouse cytokine array "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""abstract"", ""methods""], ""animal_models:Nf1-/-"": [""abstract""], ""computational_tools:R"": [""abstract"", ""methods""], ""computational_tools:ImageJ"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:FlowJo"": [""methods""]}",False
10684924,10.1093/nar/28.6.1307,Cold shock induces the insertion of a cryptic exon in the neurofibromatosis type 1 (NF1) mRNA.,Nucleic Acids Res,2000,1234,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ssion based on the flexibility in the selection of splice sites. In this manuscript we present the characterisation of an alternative splicing of the NF1 pre-mRNA induced by cold-shock conditions. We demonstrate that the accuracy of the splicing mechanism was perturbed after keeping samples for a short"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Alternative splicing is a regulatory process of gene expression based on the flexibility in the selection of splice sites. In this manuscript we present th"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
10705390,10.5858/2000-124-0382-AUMFMA,A unique method for mutation analysis of tumor suppressor genes in colorectal carcinomas using a crypt isolation technique.,Arch Pathol Lab Med,2000,1035,8123,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials and methods Patients Tumor specimens were obtained from 92 patients with CRC with microsatellite stability (MSS) who had undergone colectomy at I"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""abstract"", ""methods""]}",False
10712197,10.1086/302809,Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain.,Am J Hum Genet,2000,2062,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""More than 500 unrelated patients with neurofibromatosis type 1 (NF1) were screened for mutations in the NF1 gene. For each patient, the whole coding sequence and all splice sites were studied for aberrations, either b"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""More than 500 unrelated patients with neurofibromatosis type 1 (NF1) were screened for mutations in the NF1 gene. For each patient, the whole coding sequ"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
10712203,10.1086/302812,Functional analysis of the neurofibromatosis type 2 protein by means of disease-causing point mutations.,Am J Hum Genet,2000,1677,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Despite intense study of the neurofibromatosis type 2 (NF2) tumor-suppressor protein merlin, the biological properties and tumor-suppressor functions of merlin are still largely unkno"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
10887156,,Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2.,Genes Dev,2000,825,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Hemizygosity for the NF2 gene in humans causes a syndromic susceptibility to schwannoma development. However, Nf2 hemizygous mice do not develop schwannomas but mainl"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
11080503,10.1074/jbc.M009202200,Neurofibromin GTPase-activating protein-related domains restore normal growth in Nf1-/- cells.,J Biol Chem,2001,1241,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ntal cellular processes by cycling between an active GTP-bound conformation and an inactive GDP-bound form. Neurofibromin, the protein product of the NF1 tumor suppressor gene, and p120GAP are GTPase-activating proteins (GAPs) for p21(Ras) (Ras) and negatively regulate output by accelerating GTP hydrol"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Members of the Ras superfamily of signaling proteins modulate fundamental cellular processes by cycling between an active GTP-bound conformation and an inac"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
11106646,10.1074/jbc.M006708200,Hierarchy of merlin and ezrin N- and C-terminal domain interactions in homo- and heterotypic associations and their relationship to binding of scaffolding proteins EBP50 and E3KARP.,J Biol Chem,2001,1306,470,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods Hepatocellular carcinoma cell lines such as MHCC-1, MHCC97-H, SF7721, SMMC7721, Hep3B, and HepG2 were chosen in this study. We first examined the expression and the"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""abstract"", ""methods""]}",False
11159187,10.1016/S0002-9440(10)63992-2,Tumorigenic properties of neurofibromin-deficient neurofibroma Schwann cells.,Am J Pathol,2001,1713,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Dermal and plexiform neurofibromas are peripheral nerve sheath tumors that arise frequently in neurofibromatosis type 1. The goal of the present study wa"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
11316791,10.1101/gad.189601,"The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44.",Genes Dev,2001,767,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The neurofibromatosis-2 (NF2) gene encodes merlin, an ezrin-radixin-moesin-(ERM)-related protein that functions as a tumor suppressor. We found that merlin me"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
11356864,10.1523/JNEUROSCI.21-11-03764.2001,Bipartite interaction between neurofibromatosis type I protein (neurofibromin) and syndecan transmembrane heparan sulfate proteoglycans.,J Neurosci,2001,1258,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""The neurofibromatosis type 1 (NF1) gene encodes a large tumor suppressor protein (neurofibromin). Although it is known to possess Ras GTPase-activating protein (GAP) activity, the cel"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""The neurofibromatosis type 1 (NF1) gene encodes a large tumor suppressor protein (neurofibromin). Although it is known to possess Ras GTPase-activating protei"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
11368764,10.1042/0264-6021:3560377,"The neurofibromatosis 2 protein product merlin selectively binds F-actin but not G-actin, and stabilizes the filaments through a lateral association.",Biochem J,2001,1516,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The neurofibromatosis 2 protein product merlin, named for its relatedness to the ezrin, radixin and moesin (ERM) family of proteins, is a tumour suppressor wh"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
11380622,10.1046/j.1365-2443.2001.00432.x,Identification of the cis-acting region in the NF2 gene promoter as a potential target for mutation and methylation-dependent silencing in schwannoma.,Genes Cells,2001,1333,3600,0,1,2,3,"{""cell_lines"": {""N10"": ""de94c5d9-6feb-402f-a0c6-6ac3389907c6""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods and results We analysed 109 CNS WHO Grade I meningiomas, comparing the Merlin immunostaining patterns with  NF2  gene status. Complete loss of Merlin expre"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""ate NF2 expression. Luciferase assay and site-directed mutagenesis demonstrated that a 70-base pair (bp) region (-591 to -522 bp from the translation start site) was essential for the basic expression of the NF2 gene. A gel mobility shift assay indicated recognition by nuclear protein of the unusually l"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}, ""cell_lines:N10"": {""context"": ""repancies or difficulties were discussed to reach a consensus. Some selected cases were also immunostained with monoclonal antibodies for CD3 (clone LN10, 1:50; Leica Biosystems, Nussloch, Germany), CD20 (clone L26, 1:1; Roch Diagnostics) and CD68 (clone Kp\u20101, 1:200; Agilent technologies, Santa Clara, "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""computational_tools:R"": [""abstract"", ""methods""], ""computational_tools:STAR"": [""abstract""], ""cell_lines:N10"": [""methods""]}",False
11404331,10.1093/genetics/158.2.667,A systematic screen for dominant second-site modifiers of Merlin/NF2 phenotypes reveals an interaction with blistered/DSRF and scribbler.,Genetics,2001,1243,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Merlin, the Drosophila homologue of the human tumor suppressor gene Neurofibromatosis 2 (NF2), is required for the regulation of cell proliferation and d"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
11432873,10.1074/jbc.M105792200,Schwannomin isoform-1 interacts with syntenin via PDZ domains.,J Biol Chem,2001,1407,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The neurofibromatosis type 2 gene (NF2) is involved in the pathogenesis of benign tumors of the human nervous system. The NF2 protein, called schwannomin or m"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
11433044,10.1093/nar/29.13.e68,Quantification of splice variants using real-time PCR.,Nucleic Acids Res,2001,1063,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""of real-time PCR have made this technique attractive to study its application in quantification of splice isoforms. We use skipping of exon 37 in the NF1 gene as a model to compare and evaluate the different strategies for quantitating splice variants using real-time PCR. An overview of three different"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""A reliable and robust method for measuring the expression of alternatively spliced transcripts is an important step in investigating the significance of "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
11435472,10.1084/jem.194.1.57,"Hyperactivation of p21(ras) and the hematopoietic-specific Rho GTPase, Rac2, cooperate to alter the proliferation of neurofibromin-deficient mast cells in vivo and in vitro.",J Exp Med,2001,1731,7985,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Materials and Methods Animals. \n Nf1 \n +/ \u2212 mice were obtained from Tyler Jacks at the Massachusetts Institute of Technology (Cambridge, MA) in a C57BL/6.129 background and backcrossed f"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and Methods Animals. \n Nf1 \n +/ \u2212 mice were obtained from Tyler Jacks at the Massachusetts Institute of Technology (Cambridge, MA) in a C57BL/6.1"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""abstract"", ""methods""], ""computational_tools:R"": [""abstract"", ""methods""]}",False
11438454,10.1016/S0002-9440(10)61673-2,NF1 deletions in S-100 protein-positive and negative cells of sporadic and neurofibromatosis 1 (NF1)-associated plexiform neurofibromas and malignant peripheral nerve sheath tumors.,Am J Pathol,2001,1435,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ard molecular genetic analysis. Its mixed composition typically includes Schwann cells, fibroblasts, perineurial-like cells, and mast cells. Although NF1 loss of heterozygosity has been reported in subsets of PNs, it remains uncertain which cell type(s) harbor these alterations. Using a dual-color fluo"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Although plexiform neurofibroma (PN) is thought to represent a benign neoplasm with the potential for malignant transformation (malignant peripheral nerve sheath tumor"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
11533205,10.1128/JVI.75.19.9427-9434.2001,Retroviral integration at the Epi1 locus cooperates with Nf1 gene loss in the progression to acute myeloid leukemia.,J Virol,2001,1432,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ouse model of JMML through reconstitution of lethally irradiated mice with hematopoietic stem cells homozygous for a loss-of-function mutation in the Nf1 gene (D. L. Largaespada, C. I. Brannan, N. A. Jenkins, and N. G. Copeland, Nat. Genet. 12:137-143, 1996). In the course of these experiments, we foun"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Juvenile myelomonocytic leukemia (JMML) is a disease that occurs in young children and is associated with a high mortality rate. In most patients, JMML has a progressive course leading to death by virtue of infect"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
11535133,10.1042/0264-6021:3580727,Binding of the merlin-I product of the neurofibromatosis type 2 tumour suppressor gene to a novel site in beta-fodrin is regulated by association between merlin domains.,Biochem J,2001,1456,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The mechanism underlying the tumour-suppressor activity of the neurofibromatosis type 2 (NF2) gene product, merlin, is largely undefined but there is evidence that the b"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
11544276,10.1172/JCI12758,Quantitative effects of Nf1 inactivation on in vivo hematopoiesis.,J Clin Invest,2001,1084,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""The NF1 tumor-suppressor gene is frequently inactivated in juvenile myelomonocytic leukemia, and Nf1 mutant mice model this myeloproliferative disorder (MPD)"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""The NF1 tumor-suppressor gene is frequently inactivated in juvenile myelomonocytic leukemia, and Nf1 mutant mice model this myeloproliferative disorder (MPD). Comp"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
11703924,10.1016/s1534-5807(01)00009-0,"The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling.",Dev Cell,2001,972,5288,0,0,2,2,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials and Methods Tumor procurement, immunohistochemistry, and FoundationOne test A meningioma appearing as a firm, light tan-to-brown, fibrous mass (2"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""termined after 3 days by measuring the fluorescent readout of resazurin assays, and IC 50  (50% inhibitory concentration) values were estimated using GraphPad Prism v10 ( 17 ). For drug combinations, AG-NF2-Men and Ben-Men-1 cells seeded at 4,000 and 2,000 cells/well, respectively, as 8 \u00d7 8 matrices in 96-well pl"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""abstract"", ""methods""], ""computational_tools:GraphPad Prism"": [""methods""]}",False
11719502,10.1074/jbc.C100553200,p21-activated kinase links Rac/Cdc42 signaling to merlin.,J Biol Chem,2002,1289,14946,0,1,3,4,"{""cell_lines"": {""HEK293"": ""7b6dcc42-3c32-4008-8b2c-309aa01b17be""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""ImageJ"", ""R"", ""GraphPad Prism""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods Sex as a biological variable. Our study examined male and female animals, and similar findings are reported for both sexes. Generation of Nf2-cKO mice. The animals were main"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:HEK293"": {""context"": ""mental Table 2 . For lentivirus packaging, the second-generation packaging plasmids (psPAX2 and pMD2.G) and lentivirus vector were cotransfected into HEK293T cells (3101HUMGNHu17, BMCR) using the Lipofectamine 8000 transfection reagent (Beyotime, C0533) following manufacturer\u2019s instructions as described ("", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": "" embryo collection. EdU staining was performed based on the BeyoClick EdU-594 (C0078S, Beyotime). The Edu +  osteoprogenitor cells were counted using ImageJ (NIH) for data analysis. EdU +  cells were calculated from 3 samples using ImageJ. Apoptosis assay. The apoptosis was determined by TUNEL labeling as"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""s, 1-way or 2-way ANOVA was performed. A  P  value less than 0.05 was considered statistically significant. Statistical analyses were performed using GraphPad Prism 9 (GraphPad Software). Study approval. All the animal experiments were approved by the animal committee of Zhejiang Sci-Tech University (201911001). "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""abstract"", ""methods""], ""cell_lines:HEK293"": [""methods""], ""computational_tools:ImageJ"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""]}",False
11727199,10.1086/337952,"C-->U editing of neurofibromatosis 1 mRNA occurs in tumors that express both the type II transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing enzyme.",Am J Hum Genet,2002,1793,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""C-->U RNA editing of neurofibromatosis 1 (NF1) mRNA changes an arginine (CGA) to a UGA translational stop codon, predicted to result in translational termination of the edited mRNA. Previous stud"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""C-->U RNA editing of neurofibromatosis 1 (NF1) mRNA changes an arginine (CGA) to a UGA translational stop codon, predicted to result in translational termina"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
11756419,10.1074/jbc.M109979200,Structural basis for neurofibromatosis type 2. Crystal structure of the merlin FERM domain.,J Biol Chem,2002,730,21958,0,1,4,5,"{""cell_lines"": {""HEK293"": ""7b6dcc42-3c32-4008-8b2c-309aa01b17be""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""ImageJ"", ""R"", ""GraphPad Prism"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials and Methods Drosophila  stocks and genetics Drosophila melanogaster  (RRID:NCBITaxon_7227) crosses and staging were done at 25 \u00b0C. The following "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:HEK293"": {""context"": ""idoma Bank, DCAD2, RRID:AB_528120, 1:100), anti-Cut (Developmental Studies Hybridoma Bank, 2B10, RRID:AB_528186, 1:100). For immunostaining of NF2 in HEK293T and MDCK cells, cells cultured in chamber slides were fixed in 4% formaldehyde for 15 min, followed by permeabilization in PBST. Fixed cells were th"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": "" on glass slides. Slides were then dried on a 50 \u00b0C heat block overnight before imaging on a Leica M205 FA microscope. Wing sizes were measured using ImageJ and statistical analysis was performed using Graphpad Prism software. The wing size of  nub - Gal4  flies was used as a reference. Immunofluorescence"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""heat block overnight before imaging on a Leica M205 FA microscope. Wing sizes were measured using ImageJ and statistical analysis was performed using Graphpad Prism software. The wing size of  nub - Gal4  flies was used as a reference. Immunofluorescence and western blot Drosophila  third instar larval wing discs"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""iscs, heat shocks were carried out 2\u20134 days after egg-laying in a 37 \u00b0C water bath for 1 hour before returning the larvae to 25 \u00b0C. Wandering third instar larvae were dissected for immunostaining. For clonal induction in adult ovaries, heat shocks were carried out 2 days after eclosion in a 37 \u00b0C incuba"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""abstract"", ""methods""], ""cell_lines:HEK293"": [""methods""], ""computational_tools:ImageJ"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:STAR"": [""methods""]}",False
11784085,10.1006/dbio.2001.0504,Allele-specific non-CpG methylation of the Nf1 gene during early mouse development.,Dev Biol,2001,998,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Recent reports of cytosine methylation occurring at CpA and CpT dinucleotides in murine ES cells as well as in Drosophila have renewed interest in meth"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
11809806,10.1128/MCB.22.4.1150-1157.2002,"The neurofibromatosis type 2 gene product, merlin, reverses the F-actin cytoskeletal defects in primary human Schwannoma cells.",Mol Cell Biol,2002,1664,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Schwannoma tumors, which occur sporadically and in patients with neurofibromatosis, account for 8% of intracranial tumors and can only be treated by surgical removal."", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
11896214,10.1038/labinvest.3780429,NF1 tumor suppressor mRNA is targeted to the cell-cell contact zone in Ca(2+)-induced keratinocyte differentiation.,Lab Invest,2002,1348,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""We have previously shown that NF1 (type 1 neurofibromatosis) p21ras GTPase-activating tumor suppressor protein undergoes major relocalization during the formation of cell-cell junctio"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""We have previously shown that NF1 (type 1 neurofibromatosis) p21ras GTPase-activating tumor suppressor protein undergoes major relocalization during the formati"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
11996670,10.1042/BJ20020060,The 4.1/ezrin/radixin/moesin domain of the DAL-1/Protein 4.1B tumour suppressor interacts with 14-3-3 proteins.,Biochem J,2002,1374,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The Protein 4.1 family contains at least two members that function as tumour suppressors, the neurofibromatosis 2 gene product merlin and the recently ident"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
12000789,10.1101/gad.226302,Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse.,Genes Dev,2002,699,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Biallelic NF2 gene inactivation is common in sporadic and in neurofibromatosis type 2 (NF2)-related meningiomas. We show that, beginning at four months of age, thirty percent of mice with arachnoidal"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
12057013,10.1186/1471-2164-3-13,Complex splicing pattern generates great diversity in human NF1 transcripts.,BMC Genomics,2002,1280,4325,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""e (Invitrogen) and random hexamers (Amersham Biosciences). RT-PCR library formation and PCR analysis Primers used for the amplification of the total  NF1  cDNA in 5 overlapping fragments were as described [ 17 ]. Reactions were performed as described [ 13 ]. The PCR products were cloned in the pCR2.1-T"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and methods RNA isolation and cDNA preparation RNA was isolated from fresh blood leukocytes from two normal individuals using TRIzol LS Reagent ("", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""transcripts In order to clearly describing the identity (ID) of the transcripts, following nomenclature was used: \u2022 The ID of all transcript variants start with 'NF1' followed by '-'. \u2022 Sequence changes are all described at the RNA level, with 1 = first base of methionine (ATG) at the start. Numbering s"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""abstract"", ""methods""], ""computational_tools:R"": [""abstract"", ""methods""], ""computational_tools:STAR"": [""abstract"", ""methods""]}",False
12077339,10.1128/MCB.22.14.5100-5113.2002,Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation.,Mol Cell Biol,2002,1503,0,0,2,1,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {""Nf1flox/flox"": ""d2dec4d7-24be-4218-b7b5-63349158aa15""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Individuals with the neurofibromatosis 1 (NF1) inherited tumor syndrome develop low-grade gliomas (astrocytomas) at an increased frequency, suggesting that the NF1 gene is a critical growth regul"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""animal_models:Nf1flox/flox"": {""context"": ""lly expressed in astrocytes by embryonic day 14.5. Successive intercrossing with mice bearing a conditional Nf1 allele (Nf1flox) resulted in GFAP-Cre Nf1flox/flox (Nf1(GFAP)CKO) animals. No astrocytoma formation or neurological impairment was observed in Nf1(GFAP)CKO mice after 20 months, but increased numbers "", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Individuals with the neurofibromatosis 1 (NF1) inherited tumor syndrome develop low-grade gliomas (astrocytomas) at an increased frequency, suggesting that the NF1 gene is a c"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""animal_models:Nf1flox/flox"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
12082543,10.1038/sj.neo.7900249,Mouse models of neurofibromatosis 1 and 2.,Neoplasia,2002,826,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""matoses represent two of the most common inherited tumor predisposition syndromes affecting the nervous system. Individuals with neurofibromatosis 1 (NF1) are prone to the development of astrocytomas and peripheral nerve sheath tumors whereas those affected with neurofibromatosis 2 (NF2) develop schwan"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""The neurofibromatoses represent two of the most common inherited tumor predisposition syndromes affecting the nervous system. Individuals with neurofibromatos"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
12095621,10.1016/s0014-5793(02)02887-9,Quantification of NF1 transcripts reveals novel highly expressed splice variants.,FEBS Lett,2002,629,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Previously, we have shown that the NF1 gene gives rise to multiple novel splice variants. In the present study, nine NF1 variants were quantified by real-time PCR in various human tissues."", ""confidence"": 0.7999999999999999, ""is_development"": true, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Previously, we have shown that the NF1 gene gives rise to multiple novel splice variants. In the present study, nine NF1 variants were quantified by rea"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
12124168,10.1016/s1535-6108(02)00078-8,Thinking beyond the tumor cell: Nf1 haploinsufficiency in the tumor environment.,Cancer Cell,2002,155,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Deletion of both copies of the Nf1 gene in Schwann cells combined with Nf1 heterozygosity in the tumor environment promotes neurofibroma formation in mice."", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Deletion of both copies of the Nf1 gene in Schwann cells combined with Nf1 heterozygosity in the tumor environment promotes neurofibroma formation in mice."", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
12130630,10.1074/jbc.C200125200,Mutant products of the NF2 tumor suppressor gene are degraded by the ubiquitin-proteasome pathway.,J Biol Chem,2002,1162,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Neurofibromatosis type 2 (NF2), a syndrome associated with multiple tumors of the nervous system, mostly schwannomas, is caused by mutations in the NF2 tu"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
